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Bullous pemphigoid (BP) antibodies are known to 
react with an antigen of the basement membrane zone 
(BMZ) of squamous epithelia and produce, by the indi-
rect immunofluorescence technique, linear fluorescence 
at the BMZ. Direct and indirect immunoelectron mi-
croscopy (IEM) have demonstrated BP antigen to be 
within the lamina Iucida, in close association with the 
basal cell membrane. Trypsin-dissociated epidermal 
basal cells bind BP antibodies in a polar distribution, 
presumably because the BP antigen is restricted to the 
dermal pole of the basal cell membrane. 
In this study we have utilized newborn BALB/c mouse 
skin to obtain both dissociated basal cells (by trypsini-
zation) and epidermal sheets (by dithiothreitol treat-
ment) . We show that viable basal cells, which are im-
permeable to lgG molecules, do not react with BP anti-
bodies. When the basal cell plasma membrane is dis-
rupted by cytospin centrifugation, air drying, freezing 
and thawing, or hypotonic lysis, or permeated by non-
ionic detergents (saponin), cells become reactive with 
BP antibodies. Basal cell cytoskeletons, prepared by 
sequential treatment with Triton X-100, deoxyribonu-
clease, and 2M NaCl continue to react with BP antibod-
ies. 
Similarly, viable epidermal sheets fail to bind BP 
antibodies. When epidermal sheets are treated with non-
ionic detergents, water, or freezing and thawing prior 
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to incubation with BP antibodies, linear BMZ fluores-
cence is observed. 
IEM study of saponin-treated basal cells shows the 
immunoreactants to be localized on intracytoplasmic 
vacuoles which represent internalized hemidesmosomes. 
IEM of permeated epidermal sheets shows the immuno-
reactants as aggregates on the inner surface of the der-
mal pole of the basal cell membrane . 
These observations suggest that the BP antigen is 
intracellular and is in close association with the basal 
cell cytoskeleton and hemidesmosomes. 
Bullous pemphigoid (BP) is a blistering disease characterized 
by the presence of circulating autoantibodies which react with 
an antigen found in t he basement membrane zone (BMZ) of 
skin and other stratified squamous epithelia [1) . T he precise 
physiologic functio n and the biochemical characterization of 
the BP antigen remain unclear. 
The localization of the BP antigen has been studied previ-
ously, using both immunofluorescence (IF) and immunoelec-
tron microscopic (IEM) techniques. Using standard indirect IF, 
employing sera from patients with BP, it is established that 
BP antibodies bind t he BMZ, producing a linear pattern of 
fluorescence on vertical sections of squamous epithelium. Di-
rect and indirect IEM using immunoperoxidase techniques 
have shown that BP autoant ibodies are deposited within the 
lamina Iucida of the BMZ, in close apposition to t he basal cell 
plasma membrane (2- 4). T his would imply t hat the BP antigen 
is located t here as well. 
When separation of t he epidermis from the dermis is induced 
by trypsin , negative pressure, or chaotropic agents, and indirect 
IF with BP serum is performed, the fluorescence remains with 
the epidermis and no dermal flu orescence is seen [5,6]. If 
epidermal cells are dissociated from each other by t rypsin to 
form a cell suspension, and attached to glass slides by centri-
fugation or air drying prior to performing indirect IF, t he basal 
cells show a polar cap of fluorescence [7- 9]. This limited area 
of fluorescence presumably represen ts t he dermal pole of the 
basal cell. The ul t rastructural localization of the BP antigen in 
basal cells in suspension has not been reported as yet. 
An unexplained finding made by us is that if the indirect IF 
procedure using BP serum is performed on epidermal cells in 
suspension, very few basal cells show positive fluorescence. 
Similarly , it has not been possible to purify basal cells from 
epidermal ce ll suspensions by immunoaffinity procedures in 
which it is necessary to "coat" the basal cells in suspension 
with BP antibodies (unpublished data) . 
In this paper, we desc ribe a series of observations which show 
that both in intact epidermis, as we ll as in basal cell suspen-
sions, t he reactivi ty of BP ant ibodies with basal cells occurs 
on ly in those cells whose plasma membranes a re permeable to 
antibody molecules. Intact, viable epidermal basal cells do not 
bind BP antibodies. IEM shows that BP an tibodies bind an 
int racellular ant igen and that t his ant igen is localized in the 
area of t he basa l cell hemidesmosome. 
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MATERIALS AND METHODS 
1 mmu.n.ofluorescence T echniques 
IF techniques were performed as described by Beutner et a l [10]. 
The fluorescein isothiocyanate (F ITC) a nt ihuman lgG (Cappel, Coch-
ranville, Pennsylva nia) had t he following characteristics: tota l protein, 
24.5 mg/ml ; ant ibody prote in, 5 mg/ml; and the fluorescein/ protein 
ratio was 3.19. BP se ra were obtained from 3 patients with t he typica l 
clinica l, his tologic, a nd immunologic features of BP, and were tested 
separately. BP serum a nd normal human serum (NHS) were used at 
1:20 dilution in phosphate-buffered saline (PBS) in a ll experiments. 
All specimens were examined with a Zeiss fluorescent microscope 
equipped with epifluorescence. 
Preparation of Epidermal S heets 
The skins of neonatal BALB/c mice were immersed in Medium 199 
(M -199) (Flow Laboratories, Rockville, Maryland) containing 10 mM 
di thiothreito l (DTT) for 90 min at 37"C according to Epstein et a l 
[11]. Intact epiderm al sheets were separated from t he dermis with 
forceps and washed repeatedly wi t h M-199. Basal cells that were 
subsequent ly released from t he epidermal sheets by t rypsini zation 
s howed a 95% viability by t he t rypan blue assay. 
Preparation of Epidermal Basal Cell Suspensions 
Epidermal basa l cells from newborn BALB/c mice (0- 24 h old) were 
obtained as described by Marcelo eta! [12]. Briefly, p ieces of skin were 
incuba ted with 0.25 % tryps in (Sigma, St. Louis, Missouri) in M-199 at 
37"C for 60 min. The separated epidermis and dermis were gently 
scraped in M-199 containing 50 IU/m l of penicillin a nd 50 mg/m l of 
st reptomycin (P&S) (Flow Labs), supplemented with 13% fetal calf 
serum (FCS) (KC Biologicals, Lenexa, Ka nsas). The resulting cell 
suspension was subjected to disco nt inuous density grad ient cen t ri fu-
gation using a 12, 15, 18, a nd 20% Ficoll gradient for 30 min at 250 g 
at 4"C. Epidermal basa l cells were recovered in the 20% Ficoll fraction 
a nd washed wit h M -199 conta ining P&S and 13% FCS. More than 
90% of the cells t hus obtained were basal ce lls as judged by their 
morphology. The viabi li ty of t he basal ce lls, as measured by t rypan 
blue exclusion , was approximately 85- 90%. 
Treatment of Epidermal S heets and Epidermal Basal Cells Prior to 
1 mmun.oflu.orescen.ce Procedures 
The procedures we employed a re outlined below, a nd shown in Fig 
1. Viable epidermal s heets were: (a) incubated with BP serum, washed, 
a nd 6- llm cryosections t reated wi t h FJTC a ntihuman JgG; (b) first 
cryosectioned and then exposed to BP serum and FTTC antih uman 
lgG; (c) t reated wit h agents t hat would permeabilize t he cell membrane 
to the ant ibody molecules. These included 0.1 % saponin (Sigma) in 
PBS, distilled water, or repeated freezing and t hawing. Subsequent to 
t his, the t issue was exposed to BP serum , a nd cryosections t reated wit h 
FITC antihuman JgG. 
Viable basal ce ll suspensions were: (a) incubated with BP serum , 
washed, and trea ted with FITC antihum an lgG; (b) attached to glass 
slides by cent rifugation (Cytospin , Sha ndon Sout hern , Sewickley, 
Pennsylvania) or by ai r drying a nd t hen t reated wit h BP serum and 
FITC antihuma n lgG; (c) permeahilized wit h 0.1% saponi n, distilled 
wate r, or repeated freeze- thawing. Subsequently, the cells maintained 
in suspension were exposed to BP serum , followed by FITC a nt ihuman 
IgG; (d) t reated sequentially with 0.1% Triton X-100 (Sigma) in PBS, 
0.025% deoxy ribonuclease I (Sigma) with 5 mM MgSO, in PBS, a nd 2 
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FIG 1. Demonstration of BP a nt igen in · basa l ce lls and epidermal 
sheets. 
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M NaCI. The cytoskeletons thus obtained were t reated wi t h BP serum 
and then FITC a ntihuma n lgG either in suspension or attac hed to 
glass slides; (e) finally, freshly prepa red basal ce ll suspensions were 
maintained in M-199 at 4"C for 2- 10 days. The cell viabili ty of t h e 
suspensions was 85- 90% initia lly, 70- 80% at 2 days, and less t han 10% 
at 10 days, as demonstrated by t rypan blue exclus ion. At each of t hese 
t ime poin ts, the suspensions were exposed to BP serum and t he 
fluoresce nt conjugate. 
Control experiments were performed in parallel using norm al huma n 
serum in place of the BP serum . 
Localization. of BP Antigen at Various Time Point.s During 
Trypsinization of Whole Shin. 
Whole skins from neonatal BALB/c mice were incubated wi t h 0.25 % 
t rypsin in M-199 at 37"C. Representative samples were obtained a fte r 
10, 20, 30, and 60 min of trypsinization , washed with M-199 containin g 
13% FCS, and 6-llm cryosections were obta ined. These were exposed 
to BP serum, and then FITC a nt ihuman IgG. 
Electron. Microscopy and 1mmun.oelectron Microscopy 
For electron microscopic (EM) examination, epidermal sheets as 
well as basal cells were fixed with 2.5 % glutara ldehyde, postfixed wi t h 
1% osmium tetroxide (OsO,) , dehydrated in a series of ascending 
alcohol concentrations, a nd embedded in British araldite (a ll from 
Polysciences, Warrington , Pennsylvania). Ultrathin sections were 
stained with ura nyl acetate and Reynold 's lead citrate solution, a nd 
examined with a JOEL 100S t ra nsmission electron microscope (JOEL 
Ltd., Tokyo, Japan). 
For IEM localization of BP antigen , epidermal sheets and basal cells 
were incubated with BP serum for 30 min , washed in PBS, and treated 
with perox idase- labeled goat antihuman IgG (Cappel) for 30 min. 
Additional specimens were pretreated wit h 0.1% saponin in PBS for 
10 min before exposure to BP serum and the peroxidase conjugate. 
After washing in PBS, t he specimens (epidermal sheets or ce lls) we re 
fixed in 1% glutaraldehyde for 5 min, washed in PBS, t reated with 
dia minobenzidine (DAB) (S igma) for 20 min , then fixed in 2.5 % 
gluta ra ldehyde and prepared for EM exam ination. Ultrathin sections 
were observed without counte rstaining for better visualization of DAB 
deposit ion . 
RESULTS 
Demonstration of BP Antigen in Epidermal S heets 
Viable epidermal s heets that we re incubated with BP serum 
prio r to sectioning a nd treatment with FITC antihuman lgG 
did not dem on strate pos itive BMZ fluo rescen ce in most of t h e 
specime n (Fig 2c ). Occasio na l segm ents of t he BMZ s howed 
flu o rescen ce limited to scattered individua l basal cells (Fig 2c, 
a rrows) . If t he sam e sections were reincubated with BP serum 
a nd then FITC antihuman lgG, they showed continuous linear 
f1u o rescen ce along the BMZ t hroughout t he e n t ire spec ime n . 
Similar con tinuous linear fluorescen ce a long the BMZ was seen 
in specime n s processed by standa rd indirect IF technique, in 
which t he epide rmis was first sectioned, a nd t hen t reated 
sequentia lly with BP serum a nd FITC a n tihuman IgG (Fig 2b). 
Epidermal sheets pretreated wi t h agents that would permea-
bilize the cell membrane a nd incubated with BP serum prior to 
sectioning a lso showed co n t inuous BMZ f1uo rescen ce (Fig 2d). 
There was no difference if saponin, distill ed water, or freeze-
t hawin g was employed. 
In a ll para lle l control exerime n ts us ing NHS in pl ace of BP 
serum, no BMZ fluorescence was observed (Fig 2a) . 
Demonstration of BP Antigen in Basal CelLs 
Only 10- 15% of fres hly prepared epidermal basal cells (via-
bility 85- 90 % ) t reated with BP serum and then FITC antihu-
man lgG in suspension showed positive fluorescen ce (Fig 3a). 
Larger, more differentiated ke ratinocytes showed no fluores-
cence. The flu orescence was limited to on e pole of t he basal 
cells, as observed previous ly by several autho rs [7- 9]. Depend-
ing o n the o rientation of t he cells on t he s lides, t he p attern of 
fluorescen ce was homogeneously arcuate on one s ide of t he cell , 
granula r a nd diffuse t hroughout t he cell , or mixed. Whe n t hese 
cell susp e ns ions were examined with both transmitted li ght 
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FIG 2. Immunofluorescence studies showing that viable epidermis 
does not bind BP antibodies. Epidermal sheets that are sectioned or 
pretreated with saponin do bind BP antibodies. a, Controls. Epiderma l 
sheets were first treated with saponin and incubated with normal 
human serum; they were then sectioned and treated with FITC anti-
human IgG. There is no flu orescence along the BMZ (arrows) . b, 
Epidermal sheets were sectioned and then incubated with BP serum 
and FITC anti human lgG. There is continuous linear fluorescence 
along the BMZ (arrows). c, Epidermal sheets were incubated with BP 
serum without saponin pretreatment, then sectioned and treated with 
FITC antihuman lgG. There is no fluorescence along most of the area 
of the BMZ; individual basal cells (arrows) have fluorescence an thei r 
dermal pole. d, Epidermal sheets were pretreated with saponin, incu-
bated with BP se rum, sectioned, and then treated with FITC antihu-
man lgG. There is continuous linear t1uarescence along the BMZ 
(arrows). a- d, X 400. (Differences in the apparent thickness of the 
epidermis in the specimens are due to the different angles at which the 
sections were made.) 
and epifluorescence in t he presence of trypan blue, it was 
observed that on ly t hose cells that fai led to exclude the dye 
demonstrated positive fluorescence . If t he cell suspensions were 
maintained at 4 oc for 2-10 days prior to performing t he indirect 
IF procedure, the percentage of nonviable cells increased, and 
there was a corresponding increase in the percentage of cells 
demonstrating positive fluorescence. 
When the epidermal cell suspensions were attached to glass 
slides by air drying or cytospin centrifugation and then exposed 
to BP serum and FITC antihuman IgG, a lmost a ll basal cells 
s howed positive polar fluorescence (Fig 3b). Similar results 
(>95% positive polar fluorescence) were obtained if t he epider-
mal cells in suspension were treated with 0.1 % saponin in PBS 
(Fig 3c), distilled water, or repeated freeze-thawing before 
exposure to BP serum and FITC antihuman lgG. 
Basal cell cytoskeletons, obtained by sequential treatment of 
the cell suspensions with 0.1 % Triton X-100, 0.025% DNase, 
and 2 M NaCL, and exposed to BP serum and FITC antihuman 
lgG also showed positive fluorescence in the same pattern 
described above (Fig 3d). 
Ultrastructural Localization. of BP Antigen. in. Epidermal 
Sheets an.d Basal Cell Suspensions 
We found that DTT split the epidermis from the dermis just 
below t he basal lamina. These epidermal sheets were suitable 
for further study because the ul trastructure of the basal cells 
was very well preserved. The lamina Iucida, the basal cell 
membrane, hernidesmosomes, and other cell organelles were 
unaltered. These findings agree with the original report of 
Epstein et a l [11]. 
In epidermal sheets that were treated with saponin prior to 
exposure to BP serum and the peroxidase conjugate, the im-
munoreactants were visualized in 100% of the basal cells (Fig 
4c ). In all cells, the immune deposits were seen exclusively 
intracellularly with only very faint, patchy deposition within 
the lamina Iucida. Deposition was visualized as regularly spaced 
dense clumps on the inner surface of the dermal pole of the 
basal cell membrane, extending in a filamentous pattern to the 
inside of the cell. The sites of deposition corresponded to the 
sites of the hemidesmosomes. No immunoreactants were seen 
in t he desmosomes. 
In epidermal sheets that were incubated with BP serum and 
peroxidase-conjugated antihuman IgG, the majority of the basal 
FIG 3. Binding of BP antibodies by trypsin-dissociated epidermal 
basal cells. a., Viable basal cells were exposed to BP serum and FITC 
antihuman lgG in suspension . Only 10- 15% of basal cells bind BP 
antibodies (a rrows) , and those basal cells also failed to exclude trypan 
blue (not shown). b, Basal cells were exposed to BP serum and FITC 
antihuman IgG after attachment to glass sl ides by cytospin centrifu-
gation . Ai'l basal cells bind BP antibodies. Tn this field, cells with the 
arcuate pattern of staining (arrows) as well as cells with the diffusely 
granular pattern (arrowheads) are seen. c, Basal cells in suspension 
were pretreated with saponin prior to incubation with BP serum and 
the fluorescent conjugate. Under these conditions, all basal cells bound 
BP antibodies. In this field all cells shown had the diffuse granular 
pattern of fluorescence. In other fields, a linear cap of fluorescence 
similar to (b) was observed. This difference in pattern of fluorescence 
is presumed to be related to the orientation of the cells on the slides 
being viewed. d, Basal cell suspensions were treated sequentially with 
Triton X -100, deoxyribonuclease, and 2 M NaCl prior to exposure to 
BP serum and the fluorescent conjugate. All basal cell cytoskelet.ons 
continue to show binding of BP antibodies in a polar distribution. Cell 
cytoskeletons tend to aggregate, thus the cell boundaries are not well 
visualized. Magnification a and b, x 400; c an.d d, x 600 
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FIG 4. Immunoelectron microscopy of epidermal sheets, separat ed 
from t he dermis by DDT. a, Sheets were incubated with saponin and 
normal human serum. No deposition of immunoreactants is seen. The 
hemidesmosomes (wh ite arrowhead) , lamina Iucida (arrow) , and basal 
lamina (bloch arrowhead ) are visualized. b, Sheets were incubated wit h 
BP serum wit hout saponin . fmmun oreactant deposit ion in t he lamina 
Iucida (a.rrow ) is faint , foca l, a nd seems t o be associated with hemides-
mosomes (white arrowhead). The basal lamina (black arrowhead) is 
shown . No in t racellular deposit ion of imrnunoreactan ts is seen. c, 
S heets were incubated with saponin and BP serum. Dense intracellular 
deposition of immunoreactants (curved arrow ) in a discontinuous pat-
tern related to hemidesmosomes is seen. Each clump of immunoreac-
tants extends from t he basal cell membrane toward the inside of the 
cell in a filamentous patte rn which is cont inuous wi t h t he tonolila-
ments. There is fa int a nd focal deposit ion of immunoreactants in the 
lamina Iuc ida (arrow ). The basal lamina (black arrowhead) is seen. 
Bars = 0.5 llm . 
cells showed no deposit ion of immunoreactants; less t han 10% 
of basal ce lls scattered throughout t he section showed deposi -
t ion of immunoreactants in t he same pattern described above. 
Deposit ion of immunoreactants in t he lamina Iucida was very 
faint and sparse (Fig 4b) . Parallel control epidermal sheets 
t reated wi th saponin and NHS did not show any immunoreac-
tant deposit ion (Fig 4a). 
T he ultrastructural features of t rypsin -dissociated epidermal 
basal cells we re similar to those reported by other investigators 
[12,13]. An in teresting fe ature in t hese basal cell s is t he pres-
ence of intracellular ves icles which tend to have a polar distri-
bu t ion. Some of these vesicles represent in ternalized plasma 
membrane and hemidesmosomes as reported by T akahashi et 
a l. t Basal celis attached to glass slides by cytospin centrifuga-
t ion were rounded and di storted in their cytoplasmic compo-
nents and the cell membranes were indistinct or absent; how-
ever, the polar in tracellular vesicles were still seen. These 
cytospin attached cell s cont inued reacting wit h BP ant ibodies 
by IF as shown in Figure 3b. 
When t rypsin -dissociated basal ce ll suspensions were t reated 
:j: T akahashi Y, Mutas im DF, Patel HP, Labib RS, Anha lt GJ, Diaz 
LA: Huma n autoantibodies against epidermal hemidesmosomes. In 
prepa ration, 1984. 
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with 0.1 % saponin, BP serum, and the peroxidase conjugate , 
the immunoreactants were found exclusively in the cytoplasm 
in the form of clumps along the outer surface of the intracellular 
vesicles described above (Fig 5a). At higher magnification 
structures resembling hemidesmosomes were seen around thes~ 
vesicles (Fig 5b, arrow) . Because ofpermeabilization ofthe cells 
and the frequent pipetting and centrifugation (for washing) , 
most of the cell components are lost except for the cytoskeleton 
and the attached vesicles. 
Localization of BP Antigen Du.rin.g Trypsinization 
The localization ofBP antigen in skin incubated with trypsin 
for different periods of time was demonstrated by sectioning 
the skin specimens and performing the indirect IF technique 
using BP serum. Before trypsinization, the BMZ showed the 
classical continuous linear fluorescence (Fig 6a). After 10 min 
of trypsinization, the epidermis had begun to separate from the 
dermis in focal areas, and the f1uorescence was seen in the 
epidermis only in a discontinuous fashion (Fig 6b) . No dermal 
fluorescence was observed. By 20 min, there is splitting within 
the malpighian layer and the fluorescence is limited to t he 
dermal pole of basal cells (Fig 6c). By 30 min, basal cells start 
to get dissociated in clumps while retaining the polar nuores-
cence (Fig 6d) . When these basal cells were purified and at-
tached to glass slides, they retained their polar binding to BP 
ntibodies (Fig 6e). 
FIG 5. Ultrastructural localiza tion of immunoreactants in trypsin-
dissoc iated epidermal basal cells, permeabilized wit h saponin a nd ex-
posed to BP serum. a, The immunoreactan ts a re deposited as clumps 
around in t racellular vesicles that are present in one pole of t he cell 
(arrow ). b, Higher magnificat ion of the area outlined in (a ). T he 
structure shown by t he arrow appea rs to represent a hemidesmosome 
wit h its attac hment plaque a nd tonofilamen ts. Bars = lllm. 
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Additional Results on the Distribution of BP Antigen in Whole 
Shin 
Indirect IF was performed using BP serum on skin that had 
been oriented in various manners prior to sectioning. T his 
prov ided sections that were vertica l, ob lique, or para llel to the 
plane of the de rma l-epidermal junction (DEJ). Vert ical sections 
demo nstrated linear and homogeneous fluorescence a long the 
BMZ (Fig 7a). T he linear sta ining became wider, less intense, 
and granular as the sections became more oblique (Fig 7b,c). 
T he absence of rete ridges in neonatal BALB/c mice skin 
permitted tak ing sections through the dermal po les of the basal 
cell s, oriented para ll el to the plane of the BMZ. In t hese 
sections the flu orescence appeared as regularly sized granules 
within t he basal cells, while t he junctional areas between basal 
ce lls showed no fluorescence (Fig 7d). Each of these granules 
presumably represents ant ibody binding to a hemidesmosome. 
It can be deduced that the linear, continuous, homogeneous 
pattern of sta ining seen in vertical sections is a resul t of having 
many of t hese granules close together at each point along the 
BMZ. 
DISCUSSIO N 
It has been known for a lmost 2 decades t hat patients wit h 
BP become sensit ized to an epidermal antigen and produce 
autoant ibodies which can be detected both in lesional skin (by 
d irect IF), and circulating in the patient's se rum (by indirect 
IF ) [1]. The autoa nt ibodies are known to react wi th an ant igen 
located in the DEJ of squamous epithelia of humans and 
animals. 
T rypsin -dissoc iated basal cells continue to bind the BP auto-
ant ibodies on one pole of the ce ll , as shown by indirect IF. In 
t he majo ri ty of studies using dissociated epidermal basal ce ll , 
t he cell suspensions have been fi rst attached to glass slides by 
ai r drying, cytospin centri fugation, or t reated with fixat ives 
such as acetone befo re incubation wi th BP serum and FITC-
labeled ant ihuman IgG [8,9]. It has been assumed that the 
limited (polar) fluorescence was due to a restricted distribu t ion 
of t he BP ant igen on the dermal face of the basa l cell plasma 
membra ne. 
This investigation was prompted by some observations that 
FIG 6. Distr ibution of BP antigen in 
mouse skin at va rious time points during 
trypsin ization, as shown by indirect im-
munofluorescence. o, Time 0 (no tryp-
sin ization): BP antibodies are bound in 
a continuous linear pattern a long the 
basement membra ne zone. b, After 10 
min of trypsinization, there is focal sep-
aration of t.he dermis from the epidermis. 
BP antibodies bind only to t.he epidermis 
in a linear but discontinuous pattern. c, 
After 20 min of trypsinization, splitting 
through the malpighian layer occu rs and 
the fluorescence is retained by the der-
mal pole of basal cells. d, After 30 min 
of t rypsinization separation of the basa l 
cells from each other occurs with reten-
tion of the polar fluorescence. e, After 60 
min , the cells are fu lly dissociated and, 
after attachment to glass slides, they 
demonstrate BP antigen in a typical po-
la r distribution. Magnification of all ftg-
ures X 400. 
cast doubt on th is assumption. The first observation was that 
if"v iable basal cells were reacted with BP antibodies and FITC 
antihuman lgG in suspension, only few basal cells showed 
posit ive fl uorescence. When t he indirect IF was performed on 
cell s attached to glass slides, all the basal cells showed positive 
fluo rescence. It was also noted that it was impossible to purify 
viable basal cells from epidermal cell suspensions by coating 
t he basal cells with BP antibodies, and then removing them 
from the suspension by immunoaffi ni ty techniques, or by using 
a fluo rescence-activated ce ll sorter. T hese observations sug-
gested that the BP antigen in viable basal cell suspensions is 
not exposed to extracellular BP IgG. 
T he data we present clearly show that basal cells whose cell 
membranes a re in tact do not react with BP antibodies, while 
those with permeated or disrupted membranes do react with 
the BP ant ibodies. T his is clearly evident from the observations 
t hat when freshly prepared basal cells are stained in suspension, 
only t he few (15 %) t hat cannot exclude trypan blue bind BP 
ant ibodies. In cont rast, when cells are attached to glass slides 
or t reated with permeabili zing agents (saponin, freeze-thawing, 
hypotonic lysis, etc.), almost all bind BP antibodies. Such cell 
preparations have a trypan blue exclusion index of zero. Fur-
thermore, when cells are main tained in suspension fo r increas-
ing periods of time, t here is a positive correlation between the 
increasing percentage of nonviable cells and the percentage of 
cells that bind BP ant ibodies. Basal cell cytoskeletons, prepared 
by sequent ial treatment of basal cells with Triton X-100, 
DNase, and 2 M NaCI cont inue to bind BP ant ibodies in a 
polar distribut ion. 
All t he above observations show that BP ant igen is unavail-
able to react wit h BP ant ibodies in viable basal cells with intact 
cell membranes; when the integrity of the cell membrane is 
disrupted basal cells become reactive with BP ant ibodies. This 
would imply that BP antigen in dissoc iated basal cells is intra-
cellular rather than on the cell surface. It cannot be assumed 
that BP antige n in in tact skin is also intracellula r since epithe-
lial cells are known to undergo morphologic changes during 
trypsin dissociation. However, two observations strongly sug-
gest t hat this may be the case. F irst, when skin was sequentially 
trypsinized, it was observed that the linear band of BMZ IF 
staining in in tact skin becomes discont inuous and limited to 
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FIG 7. Distribut ion of BP antige n in mouse skin cryosectioned at 
different angles as shown by indirect IF. a, Sections vertical to the 
pl ane of t he DEJ show a continuous, homogeneous, linear fluorescence 
at the BMZ. b an.d c, The fluoresce nce becomes wider, less in tense, and 
granula r as the sections become more oblique. d, Sections through the 
derma l pole of the basal cells, parallel to the plane of the BMZ show 
t he flu oresce nce to he li mited to uniform ly sized granules within the 
basal cells, and the boundaries between cells show no fluorescence. 
Each granule presumably represents a clump of immunoreactants at 
the site of a hemidesmosome. a-c, x 600; d, x 1000. 
the dermal pole of basal cells, and finally is localized in indi-
vidual dissociated basal cells in a polar distribution . Thus it 
appears that exogenous trypsin does not affect the reactivity of 
basal cells with BP antibodies, suggesting that BP antigen in 
t hese viable cell s is either trypsin resistant or unavailable to 
interact with t he extracellular enzyme. Second, in horizontal 
sections of the skin, passing through the DEJ, the staining was 
observed as granules, limited to individual basal cell E. 
Indeed, identical resul ts were obtained when we tested t he 
ability of ep idermal sheets to bind BP antibodies by IF proce-
dures. In order to obtain intact ep idermal sheets, we incubated 
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whole skin with DTT. We chose this method because DTT 
produces a split below the basal lamina [11]. This method 
provided an epidermal sheet with a high percentage of viable 
epidermal cells, and an intact lamina Iucida and basal lamina. 
If these intact, viable epidermal sheets are incubated with BP 
serum and cryosections incubated with FITC antihuman IgG, 
the major part of the specimen shows no BMZ fluorescence. 
There are scattered small areas of BMZ fluorescence t hat 
correspond to nonviable basal cells within the epidermal sheet. 
However if the cryosections are reexposed to BP serum prior 
to incubation with FITC antihuman IgG, the sections show 
continuous, linear fluorescence along the BMZ. A similar con-
tinuous linear fluorescence of the BMZ was observed when the 
epidermal sheets were first treated with saponin, water, or 
freezing and thawing and then exposed to BP serum and 
cryosections treated with FITC antihuman IgG. This is com-
pelling circumstantial evidence that the BP antigen in epider-
mal sheets is intracellular. 
The second part of the investigation deals with the ultra-
structural localization of BP antigen in dissociated basal cells 
and epidermal sheets by the IEM technique. In view of the 
above observations, epidermal sheets and basal cells were made 
permeable prior to performing the immunoperoxidase tech-
nique. Of the known permeabilizing agents, saponin was used 
because it acts by producing small holes in the cell membranes 
while preserving the ultrastructural morphology of the cells 
[14]. The procedure was first applied to trypsin-dissociated 
basal cells. EM examination of these cells demonstrated groups 
of intracellular vesicles around the nucleus but most abundant 
in one pole of the cell. Some of these vacuoles represent 
internalized hemidesmosomes as shown by Takahashi et al.:j: 
When IEM was performed on these cell suspensions, after 
permeabilization with saponin and exposure to BP serum, the 
immunoreactants were observed as discontinuous aggregates 
on the outer surface of these vesicles, corresponding to the sites 
of internalized hemidesmosomes. No cell surface deposition of 
immunoreactants was observed. 
The procedure was next applied to epidermal sheets. Basal 
cells in these epidermal sheets do not have the trypsin-induced 
alterations of the hemidesmosome-tonofilament complex de-
scribed earlier in the text. When IEM was performed on these 
sheets after treatment with saponin and BP serum, the immu-
noreactants were observed to be largely intracellular, and oc-
curred as regularly distributed submembranous aggregates 
along the plasma membrane of the dermal pole of the basal 
cell, again corresponding closely to the location of the hemi-
desmosomes. The lamina Iucida showed a very weak deposition 
of immunoreactants. No immunoreactant deposition was ob-
served in t he desmosomes. In most areas, the deposition of 
immunoreactants on the basal cell membrane was so intense 
that the extent of deposition in t he lamina Iucida was difficult 
to assess, especially immediately underneath the clumps. How-
ever, in nonpermeabilized epidermal sheets treated with BP 
serum, where deposition would be only in the lamina Iucida, 
the intensity of immunoreactivity was so faint that it was 
obvious that the major part of BP antigen is intracellular. 
The deposition of immunoreactants at sites of hemidesmo-
somes in both dissociated basal cells and epidermal sheets, and 
the finding that basal cell cytoskeletons continue to bind BP 
antibodies, lead to the conclusion that the major part of BP 
antigen lies in the tonofilament- attachment plaque complex. 
To document that BP antigen in human skin has a similar 
locali zation to that of murine skin we have recently performed 
the same studies on human skin using both trypsin-dissociated 
basal cells ·and intact epidermis from suction blisters, and have 
observed identical results; BP antigen was located intracellu-
larly in the area of the hemidesmosomes (unpublished data). 
In view of the results reported in this paper we must recon-
sider our concepts of the in situ localization of the BP antigen 
and our understanding of the immunochemical properties of 
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this antigen. Based on results of previous IEM studies it has 
been widely accepted that BP antigen is a component only of 
the lamina Iucida of the DEJ. Direct IEM studies were per-
formed on biopsies of BP patients, taken from perilesional skin 
where there was no active inflammation or blister formation 
[2,3]. In the indirect IEM studies, freshly obtained small skin 
specimens were incubated with BP serum prior to the immu-
noperoxidase technique [4] . Under these conditions, it is con-
ceivable that the basal cell membranes were not permeable to 
BP lgG and therefore only extracellular BP antigen could be 
detected. It is important to note that the binding of BP anti-
bodies to the hemidesmosome [2] and to the inner surface of 
the basal cell plasma membrane [15] has been noted, but the 
importance of this finding was not understood. More recently, 
Yamasaki and Nishikawa [16] used a modified indirect IEM 
technique to study the localization of BP antigen in normal 
human skin by incubating frozen sections with BP serum, and 
using an immunoperoxidase technique. This procedure would 
expose intracellular antigens, whereas previous IEM techniques 
would not. They demonstrated immunoreactants in a discon-
tinuous fashion on the inner part of the dermal pole of the 
basal cell cytomembrane, showing apparent continuity with the 
tonofilaments. 
Considering the results of this and previous reports it is likely 
that there are two pools of BP antigen. The intracellular pool 
of BP antigen described in our study is associated with the 
basal cell hemidesmosome- cytoskeleton complex and is insol-
uble in common buffers and nonionic detergents, but can be 
solubilized with sodium dodecyl sulfate (SDS) or urea. The 
other pool of BP antigen is extracellular and located in the 
lamina Iucida near the basal cell plasma membrane. This cell 
surface/lamina Iucida BP antigen may be trypsin-sensitive and 
soluble in nonionic detergents. It is interesting to note that 
Gammon eta) [ 17] have studied the binding of sera from several 
patients with BP against skin substrate which has been split 
through the lamin Iucida by 1 M NaCL They found that some 
sera bound to an antigen in the epidermal side of the split, 
some bound only to the dermal side, and 1:1 few bound on both 
sides. 
The immunochemical properties of the two pools of BP 
antigen need to be defined. Diaz et al [18] showed that extracts 
of human epidermis treated with 2 N sodium thiocyanate 
released a PBS-soluble antigen that could block the binding of 
BP antibodies on human skin by indirect IF techniques. More 
recently Stanley eta! [19] used immunoprecipitation and SDS 
polyacrylamide gel electrophoresis and showed that NP-40 
(nonionic detergent) extracts of epidermal cells contained BP 
antigen. Subsequently, they were able to extract BP antigen 
from human epidermis with an SDS buffer (20]. The biochem-
ical properties (molecular weight) of BP antigen in these studies 
were different. This difference may have resulted from the use 
of different extraction procedures, sources of tissue, and/or 
detection systems for the identification of the antigen. It is 
now important to realize that the BP antigens detected in these 
studies also could have been extracted preferentially from either 
the intra- or the extracellular pools of antigen which may have 
different immunochemical properties. 
In summary, we have shown that in murine skin, the BP 
antigen is localized primarily in the basal cell hemidesmosome 
in close association with the cytoskeleton. Preliminary studies 
have shown identical findings in human skin. 
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